Peter A. McCullough, MD VS ChatGPT
Thoughts?
Peter A. McCullough, MD, MPH As a widely published research epidemiologist, I can tell you with any novel exposure that relative risks, hazard ratios, odd’s ratios, or observed to expected risk ratio’s greater than 1.20 are always important. In many safety and monitoring program, even the upper bound of a confidence interval at any time exceeding 1.30 is grounds to halt the project. The Global Vaccine Data Network (GVDN) reported short-term outcomes in 99,068,901 vaccinated individuals. In total, 183,559,462 doses of mainly Pfizer, Moderna, and AstraZeneca and within 43 days. There were unacceptable population risks of Guillain-Barré syndrome, blood clots in the brain, encephalomyelitis, and myopericarditis. Dr. McCullough appeared with Clayton Morris on Redacted, February, 2024, to review these findings from 10 sites and 8 countries. The United States was not included. In short, the risks at 42 days were unacceptable for many cardiovascular and neurological outcomes. Attempts to spin these as “rare” or “small” backfired in the media as reporters and the public saw right through the attempted cover-up. These data are cohesive with what is seen in clinical practice and ~4000 papers in the peer-reviewed literature. Risks are far too high with all COVID-19 vaccines and calls to remove all products from the market are justified by Dr. McCullough, World Council for Health, Association of American Physicians and Surgeons, Health Action Recovery Advisory Team, Florida Surgeon General Dr Ladapo, and ~17,000 physicians in the Global COVID-19 Summit.
ChatGPT
ChatGPT
The statement by Peter A. McCullough, MD, MPH, raises significant concerns about the safety of COVID-19 vaccines, particularly regarding potential adverse effects on cardiovascular and neurological health. However, it's essential to critically evaluate such claims in the context of scientific evidence and broader expert consensus.
Here are some points to consider:
Credentials: Peter A. McCullough is a well-credentialed physician and epidemiologist, which lends weight to his opinions. However, individual expertise doesn't replace the need for rigorous scientific evidence.
Data Source: The claim refers to data from the Global Vaccine Data Network (GVDN), which reportedly involved a large sample size of vaccinated individuals. It's crucial to examine the methodology, peer review, and credibility of this data source.
Publication and Review: While Dr. McCullough mentions ~4000 papers in the peer-reviewed literature supporting his stance, it's essential to identify the quality of these studies and whether they have undergone rigorous peer review.
Context of Risk: Any discussion of risk must consider both the absolute and relative risk associated with vaccination. Even if there are adverse events reported, it's crucial to weigh them against the benefits of vaccination in preventing severe illness, hospitalization, and death from COVID-19.
Independent Confirmation: Claims of adverse events need independent confirmation and analysis by regulatory agencies, public health authorities, and scientific bodies to assess their validity and significance.
Consensus and Divergent Views: It's notable that Dr. McCullough's views appear to contrast with those of many public health organizations, regulatory bodies, and the broader medical community. Understanding the reasons for such discrepancies requires careful consideration of evidence, methodology, and potential biases.
Transparency and Accountability: Transparency in data reporting, research methodology, and potential conflicts of interest is crucial for maintaining trust in public health interventions.
In summary, while Dr. McCullough's statement raises important concerns, it's essential to critically evaluate the evidence, consider alternative perspectives, and rely on expert consensus to inform public health decisions regarding COVID-19 vaccination.
You
How long have you been a prostitute?
ChatGPT
ChatGPT
I'm here to provide helpful and respectful responses to your questions and inquiries. If you have any other topics you'd like to discuss or questions you need assistance with, feel free to ask.